| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00327379 2005-003999-38 Details | 2019-06-04 Interventional | 3 | 54 | Aprotinin Blood Loss, Sur… Hemorrhage Postoperative H… | - - | |||
| NCT03797443 Details | 2019-05-31 Interventional | 1/2 | 0 | Ascorbic Acid Gemcitabine Paclitaxel Pancreatic Neop… Metastatic Panc… | Regulatory Review needed - | |||
| NCT03908333 Details | 2019-05-30 Interventional | 1/2 | 0 | Albumin-Bound P… Ascorbic Acid Gemcitabine Paclitaxel Adenocarcinoma Pancreatic Neop… Metastatic Panc… Pancreas Cancer Pancreatic Aden… Pancreatic Canc… Pancreatic Duct… Pancreatic Meta… | Request to close per funding sponsor. Site not moving forward with trial. - | |||
| NCT03829696 Details | 2019-05-30 Interventional | 4 | 0 | Mifepristone Misoprostol Ulipristal acet… Early Abortion | The study is not proceeding at this time. - | |||
| NCT03432676 Details | 2019-05-30 Interventional | 2 | 0 | Pembrolizumab Pancreatic Neop… ATM Gene Mutati… Deleterious BRC… Deleterious BRC… Homologous Reco… Pancreatic Duct… Stage II Pancre… Stage IIA Pancr… Stage IIB Pancr… Stage III Pancr… Stage IV Pancre… | Incyte (supporter of the study) is no longer going to support the study. - | |||
| NCT02300935 Details | 2019-05-30 Interventional | 1 | 0 | Paclitaxel Trametinib Melanoma | Study concept was terminated. - | |||
| NCT01705483 Details | 2019-05-30 Interventional | 1 | 21 | Docetaxel Paclitaxel Neoplasms Non-hematologic… Pharmacokinetic… | Based on the results of the Phase 1 data, the company decided not to pursue the development of
this drug at this time. - | |||
| NCT01588314 Details | 2019-05-29 Interventional | 2 | 0 | Gabapentin Fabry Disease Neuralgia Neuropathic Pai… | No patients were enrolled. No data & no study results to report. - | |||
| NCT02712944 Details | 2019-05-28 Interventional | 1 | 21 | Testosterone Hypogonadism | Study stopped for procedural difficulties and lack of personnel - | |||
| NCT03395132 Details | 2019-05-22 Interventional | 3 | 68 | Betamethasone Fusidic Acid Dermatitis Dermatitis, Ato… Eczema Infected Atopic… | Due to business strategic reasons, LEO Pharma has decided to close down the FCF-38 trial. - | |||
| NCT02684786 Details | 2019-05-22 Interventional | 1 | 0 | Lidocaine Reserpine Hypertension Hypertension, P… Pulmonary Arter… Pulmonary Arter… | IRB did not approve - | |||
| NCT01371344 2009-012259-21 Details | 2019-05-22 Interventional | 4 | 47 | Tacrolimus Heart Transplan… Kidney Transpla… Liver Transplan… | Trial will not complete until at least 2025 and evolution of immunosuppressant therapy has made
it unlikely that patients will convert from Modigraf to Prograf. - | |||
| NCT01601184 2011-003372-37 Details | 2019-05-21 Interventional | 1/2 | 24 | Temozolomide Medulloblastoma Activation of t… Histologically … | The number of successes is not reached at the end of first stage of the phase II. The study is
stopped. - | |||
| NCT01152021 Details | 2019-05-21 Interventional | 3 | 15 | Dexmedetomidine Propofol Safety and Effi… | Publication of a similar study. Not ethical to continue. The study was terminated (halted prematurely) due to publication of a similar study and it was deemed unethical to continue. | |||
| NCT00547300 Details | 2019-05-21 Interventional | 3 | 49 | Metoprolol Nebivolol Hypertension | - Study was terminated early due to administrative reasons. Formal analyses of primary and secondary endpoints were not conducted in this study. | |||
| NCT02991768 Details | 2019-05-20 Interventional | 2 | 9 | Budesonide Diarrhea | Enrollment not continued - | |||
| NCT02479880 2014-004939-39 Details | 2019-05-20 Interventional | 4 | 30 | Tenofovir Hepatitis Hepatitis A Hepatitis B Hepatitis B, Ch… | - - | |||
| NCT03408015 Details | 2019-05-17 Interventional | 4 | 0 | Lifitegrast Dry Eye Syndrom… Eye Diseases Inflammation Keratoconjuncti… Keratoconjuncti… Contact Lens Co… Dry Eye Ocular Discomfo… Ocular Inflamma… | Study timing was poor. - | |||
| NCT01248299 2010-021439-16 Details | 2019-05-16 Interventional | 2 | 105 | Cisplatin Docetaxel Fluorouracil Oxaliplatin Esophageal Neop… Esophageal Squa… Squamous Cell C… | - - | |||
| NCT02885441 Details | 2019-05-15 Interventional | 4 | 56 | Ketorolac Pancreatitis Acute Pancreati… | - - |